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Case histories of two unrelated patients suffering from sensory 
ataxic neuropathy, dysarthria/ dysphagia and external ophthal-
moplegia  (SANDO)  are  reported.  Both  patients  showed  com-
pound heterozygosity for POLG1 gene mutations, and presented 
with symptom of the clinical characteristics of SANDO. A patient 
with a p.A467T and p.W748S, well-known mutations showed a 
progressive course with early onset and multisystem involvement, 
including symptoms characteristics for mitochondrial neurogas-
trointestinal encephalomyopathy (MNGIE). The second patient 
showed a less well-known p.T251I and p.G848S mutations with 
late onset and dysphagia/dysarthria dominated, moderate symp-
toms. This later is the second published case history, when these 
POLG1 gene mutations are the possible background of late onset 
SANDO, dominantly presenting with bulbar symptoms.
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Introduction
Several  case  histories  with  a  remarkably  uniform 
clinical picture, consisting of sensory ataxic neuropathy, 
dysarthria  and  ophthalmoparesis  (SANDO)  have  been 
published during the last twenty years. Both, dominant 
and  recessive  missense  mutations  have  been  reported 
in the gene encoding the mitochondrial DNA polymer-
ase gamma enzyme (POLG1) in patients with this syn-
drome (1-3). Multi-organ involvement affecting central 
nervous  system,  liver,  stomach  and  intestine  has  been 
documented, and the possibility of sudden cardiac arrest 
also has been emphasized (4, 5). Here we report case his-
tories of two patients, with different compound hetero-
zygous POLG1 mutations, demonstrating the character-
istics of SANDO, but with different clinical pictures and 
different disease courses. 
Case histories
Patient 1
A  48  year-old  female  patient  has  been  followed  at 
our department since the age of 35. Her symptoms started 
when she was about 25 years old with paresthesia and sen-
sory loss in the extremities. She had two pregnancies in her 
early twenties, but she had to receive fertility stimulation. 
Her menopause occurred at her age of 35. At first admis-
sion, physical neurological investigation revealed limited 
eye movements into every direction, without double vi-
sion, absent deep tendon reflexes, moderate sensory loss of 
superficial sensation in all extremities, and severe sensory 
loss of deep sensations. Neither definite paresis, nor ataxia 
or gait disturbances were found. During the period of fol-
low up, the patient experienced a continuous deterioration. 
The sensory loss increased, followed by gait disturbances. 
Since her early forties, she has been suffering from repeat-
ed cramps and twitching in her muscles. She also noticed 
difficulties in swallowing of fluids, and has been suffering 
from continuous constipation. She has also been suffering 
from anxiety and depression for 5-6 years. During the last 2 
years she has become wheelchair-bound. Now, at 48 years 
of age, physical investigation showed total ophthalmople-
gia, mild dysarthria and dysphagia, moderate sensory loss 
of the superficial sensations in the upper extremities, and 
moderate superficial -, but severe deep sensory loss in the 
lower extremities. Severe gait ataxia was seen.
Chemical  laboratory  investigation  showed  normal 
parameters,  without  muscle  or  liver  enzyme  increase. 
Molecular genetic investigation with DNA sequencing of 
the POLG1 gene discovered two heterozygote mutations, 
Sensory ataxic neuropathy  
with dysarthria/dysphagia and 
ophthalmoplegia (SANDO). Two case reports
István Gáti1 3, Olof Danielsson1 3, Jon Jonasson2, Anne-Marie Landtblom3 4
1 Division of Neurosciences; 2 Division of Pathology and Clinical Genetics, Department of Clinical and Experimental Medicine;  
3 Neurology Clinic, Linköping University, Linköping; 4 Neurology Unit, Motala General Hospital, Motala, Sweden
Address for correspondence: István Gáti -Neuromuscular Unit, Department of Neurology, University Hospital, Linköping, SE-58 185 
Sweden. Fax: +46 10103 4438.  E-mail: istvan.gati@lio.seSensory ataxic neuropathy with dysarthria/dysphagia and ophthalmoplegia (SANDO)
189
a c.1399G > A giving the amino acid substitutions alanin 
to threonine (p.A467T) and a c.2243G > C, resulting in a 
trytophane to serine exchange (p.W748S). Neurophysiol-
ogy demonstrated axonal sensory and motor neuropathy. 
EEG recordings, including sleep deprivation demonstrat-
ed generalized slow-wave abnormities, with sharp waves 
in the rear temporal regions, without epileptic discharges. 
Brain MRI did not show any pathology. Constipation has 
been accounted to hypomotility of the intestines by re-
peated gastroenterological investigations. The patient re-
ceived high dose multivitamin and Q10 treatment, with-
out obvious effect furthermore, she has been receiving 
antidepressive and anxiolytic treatment.
Muscle biopsy from m tibialis anterior demonstrated 
several ragged-red -, and COX-negative fibres. Electron 
microscopy  showed  increased  amount  of  glycogen  and 
neutral fat in the intermyofibrillar and subsarcolemmal ar-
ea, mitochondrial proliferation, with bizarre mitochondrial 
morphology, crystalloid mitochondrial inclusions, and mi-
tochondria without internal structures (Fig. 1 A, B, C).
Patient 2
A 68 year-old male patient has been followed at our 
department for 3 years. His complains started in his fifties 
with moderate sensory loss in both legs, and mild gait dis-
turbances. Dysphagia, dysarthria occurred when he was 
about 60 years old. At admission, at his age of 65, the 
physical investigation revealed bilateral moderate ptosis, 
moderately limited, conjugated eye movements into every 
direction. Weak soft palatal and swallowing reflexes were 
seen. He had difficulties to swallow fluids and had nasal 
dysarthria. There were neither paresis in the muscles of 
trunk and extremities, nor physical signs of myasthenia 
were found. Deep tendon reflexes were weak in the upper 
extremities and were absent in the lower extremities. He 
had impaired touch, cold, pinprick sensation and a pro-
found loss of position and vibration senses, in the lower 
extremities. Moderate lower limb- and gait ataxia were 
seen. Autonomic functions were intact. During the last 3 
years of follow up, a mild progression was seen. 
The red- and white blood cell counts, serum electro-
lyte-, serum lipid- and liver enzyme levels, including cre-
atine kinase were within the normal range. Acethylcholin 
receptor antibodies were not found. Two mutations of the 
POLG1 gen were found by genetic investigations; muta-
tion, a c.752C > T with an aminoacid exchange from thre-
onine to isoleucine (p.T251I), and a mutation c.2542G 
> A, with exchange from glycine to serine (p.G848S). 
Neurophysiology demonstrated axonal sensory neuropa-
thy. Myography did not find any pathology. Brain MRI 
investigation described lacunar ischemia.
Muscle biopsy from m tibialis anterior showed the 
same pathology as that found in case 1, but more ragged-
red fibres were seen, and perhaps less ultra structural ab-
normities (Fig. 1 D, E, F).
Discussion
Sensory ataxic neuropathy, dysarthria and ophthal-
moparesis  (SANDO)  is  a  characteristic  clinical  triad, 
which has been attributed to mutations of the gene encod-
ing the mitochondrial DNA polymerase gamma enzyme 
(POLG1). Most cases present with an initial stage of sen-
sory neuropathy, a second stage of progressive external 
ophahlmoplegia and dysarthria, which is then followed by 
other symptoms, often with epilepsia or myoclonus (2). 
Different dominant and recessive missence mutations of 
this gene have been described with various clinical phe-
notypes (3-5). Our patients had a characteristic clinical 
triad of SANDO, and both with dysphagia/dysarthria. 
Patient  1  presented  with  a  p.A467T  and  p.W748S 
compound  heterozygous  mutations.  Both  mutations  are 
known, and several case histories with these compound 
mutations  have  been  published  (6,  7).  Central  nervous 
system involvement is characteristic of these mutations, 
as epilepsy, myoclonus, headache and bilateral high sig-
nal lesions of the posterior horn. Our patient also presented 
with central nervous system symptoms, as she had myo-
Figure 1. Gomori trichrom (A), COX/SDH (b) and ultra 
sturcture (C) of patient 1, and Gomori trichrom (D), COX/
SDH (e) and ultra sturcture (f) of patient 2.István Gáti et al.
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clonus, EEG abnormalities, and presumably her anxiety 
and depression could also – at least partly - be attributed 
to metabolic brain disturbances. Vissing and co-workers 
published case histories of two sisters with features of neu-
rogastrointestinal encephalomyopathy (MNGIE), without 
signs  of  leukoencephalopathy  (8).  They  demonstrated 
multiple mtDNA deletions, but could not find any thymi-
dine phophorylase (TP) gene mutation, the usual genetic 
background of MNGIE. Further molecular genetic inves-
tigation found three missense mutations in POLG1 gene, 
of which two (N846S and P587L) mutations were not de-
scribed before, and the third one was a known T251I muta-
tion (9). Besides dysphagia, our patient was also suffering 
from continuous constipation, mimicking the symptoms of 
MNGIE. Gonadal hypofunction and premature menopause 
have been described as a sign of multi-organ involvement 
in POLG1 mutations (4). These symptoms also complicat-
ed the clinical picture of our case. Multi-organ involvement 
and progressive course of our patient support the finding 
of Tzoulis and colleagues, that compound heterozygous 
p.A467T and p.W748S POLG1 mutations present a severe 
clinical phenotype of SANDO (7). 
The second patient had p.T251I, and p.G848S com-
pound  heterozygous  mutations.  These  mutations  have 
previously been published, only in two publications. La-
mantea and co-workers reported a member of a family, 
with ophthalmoplegia with proximal muscle weakness, 
but no detailed clinical picture and disease course were 
described (3). These authors also presented several indi-
viduals with an isolated p.T251I heterozygous mutation 
without  any  clinical  symptoms. Weiss  and  co-workers 
published a case with late onset, when these two muta-
tions were compound, and combined with a third, p.P587L 
heterozygous mutation (10). The leading symptoms of 
their patient were ophthalmoplegia, severe nasal flaccid 
dysarthria and mild tongue weakness. Besides vibration 
and joint position sensation loss, moderate gait ataxia and 
mild proximal muscle weakness were found. In our pa-
tient, the symptoms also developed relatively late, in his 
fifties, with slowly progressive sensory loss and moderate 
ataxia, which later on complicated with expressed dysar-
thria/dysphagia and moderate ophthalmoplegia.
Our patients had no definite paresis in the skeletal 
muscles of the extremities, but the muscle biopsies taken 
from m. tibialis anterior demonstrated identical pathol-
ogy, with ragged-red, COX negative fibres and mitochon-
drial ultra structural abnormities. The degree of the patho-
logical changes did not correlate with the severity of the 
clinical symptoms.
Both patients demonstrated characteristics of SAN-
DO, with axonal neuropathy, ataxia, dysarthria and oph-
thalmoplegia. Dysphagia was also present in both cases. 
The symptoms of the p.A467T and p.W748S compound 
heterozygous  patient  1  started  in  early  adulthood  and 
showed severe neuromuscular symptoms with intestinal 
and multi-organ involvement, and this case history gave 
a further evidence of POLG mutation, as a genetic back-
ground  of  MNGIE-like  syndrome.  The  patient  2  with 
p.T251I,  and  p.G848S  compound  heterozygous  muta-
tions presented with late onset, dominantly with bulbar 
symptoms. This case history shows that dysarthria/dys-
phagia could occur late in the life, as a sign of a geneti-
cally determined mitochondrial metabolic disorder.
Acknowledgements
We thank Dr. Anna Gencik, dr. Heinz D. Gabriel and 
dr. Melanie Kuhn, Center for Medical Genetic, Osnabru-
eck D-49076, Germany, and dr. Jan Vissing and Marianne 
Schwartz, Juliane Marie Center, Clinical Genetic, Univer-
sity of Copenhagen, Rigsh, hospitalet, Copenhagen DK-
2100, Denmark, for the molecular genetic investigations. 
We thank Gunnvor Sjöö, Bo Häggqvist, Bengt-Arne Fred-
riksson and Liv Gröntoft for excellent technical assistance.
References
1.   Zeviani M, Bresolin N, Gellera C, et al. Nucleus-driven multiple 
large-scale deletions of the human mitochondrial genome: a new 
autosomal dominant disease. Am J Hum Genet 1990;47:904-14.
2.  van Domburg PH, Gabreëls-Festen AA, Gabreëls FJ, et al. Mito-
chondrial cytopathy presenting as hereditary sensory neuropathy 
with progressive external ophthalmoplegia, ataxia and fatal myo-
clonic epileptic status. Brain 1996;119:997-1010.
3.  Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochon-
drial DNA polymerase gammaA are a frequent cause of autosomal 
dominant or recessive progressive external ophthalmoplegia. Ann 
Neurol 2002; 52:211-9.
4.  Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature me-
nopause, and mitochondrial DNA polymerase-gamma mutations: 
clinical and molecular genetic study. Lancet 2004;364:875-82.
5.  Lewis W, Day BJ, Kohler JJ, et al. Decreased mtDNA, oxidative 
stress, cardiomyopathy, and death from transgenic cardiac targeted 
human mutant polymerase gamma. Lab Invest 2007;87:326-35.
6.   Hakonen AH, Heiskanen S, Juvonen V, et al. Mitochondrial DNA 
polymerase W748S mutation: a common cause of autosomal re-
cessive  ataxia  with  ancient  European  origin.  Am  J  Hum  Genet 
2005;77:430-41.
7.   Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical 
disease caused by the A467T and W748S POLG mutations: a study 
of 26 cases. Brain 2006;129:1685-92.
8.   Vissing J, Ravn K, Danielsen ER, et al. Multiple mtDNA deletions 
with features of MNGIE. Neurology 2002;59:926-9.
9.   Van Goethem G, Schwartz M, Löfgren A, et al. Novel POLG mu-
tations in progressive external ophthalmoplegia mimicking mito-
chondrial  neurogastrointestinal  encephalomyopathy.  Eur  J  Hum 
Genet. 2003;11:547-9.
10.  Weiss MD, Santo RP. Sensory ataxic neuropathy with dysarthria 
and ophthalmoparesis (SANDO) in late life due to compound het-
erozygous POLG mutations. Muscle Nerve 2010;41:882-5.